Angina Pectoris

Definition:
Angina pectoris is a clinical syndrome characterized by episodes or paroxysms of chest pain or pressure,
typically located in the anterior chest.

 Angina pectoris is chest pain or pressure that happens in the front of the chest.
 It occurs when the heart does not get enough blood and oxygen to meet its needs, usually during
physical activity or stress.
 The pain happens because the heart’s oxygen demand is more than the supply.
 The severity depends on the activity that triggers it and how it affects daily life.

Types of Angina Pectoris

1. Stable Angina (Effort Angina)

o Definition: Predictable and consistent chest pain that occurs with physical exertion, emotional
stress, or heavy meals.
o Characteristics:
 Short duration (usually 5–15 minutes).
 Pain is relieved by rest or nitroglycerin.
 Usually indicates partial blockage of coronary arteries.
o Example: Chest pain while climbing stairs but not at rest.
2. Unstable Angina (Preinfarction/Crescendo Angina)
o Definition: More severe form; pain occurs more frequently, lasts longer, and may happen at
rest.
o Characteristics:
 Pain threshold is lower; can occur with minimal or no exertion.
 May precede a myocardial infarction (heart attack).
 Not fully relieved by rest or usual medication.
o Significance: Medical emergency; requires immediate assessment.
3. Intractable or Refractory Angina
o Definition: Persistent and severe chest pain that is difficult to treat.
o Characteristics:
 Disabling and affects daily life significantly.
 Usually seen in advanced coronary artery disease.
o Management: May require advanced interventions like angioplasty or bypass surgery.
4. Variant Angina (Prinzmetal’s Angina)
o Definition: Chest pain that occurs at rest, often during the night or early morning.
o Cause: Coronary artery spasm, not necessarily due to blockage.
o Characteristics:
 Reversible ST-segment elevation on ECG.
 Pain can resolve spontaneously or with nitroglycerin.
o Risk factors: Smoking, stress, cocaine use.
5. Silent Ischemia
o Definition: No chest pain, but heart muscle shows ischemia on tests like ECG or stress tests.
o Characteristics:
 Common in diabetic patients or those with neuropathy.
 Can go undiagnosed and lead to complications.
o Significance: Requires careful screening and monitoring.
Types of Angina Pectoris

Angina pectoris is classified based on its cause, pattern, severity, and response to treatment.
Each type has characteristic features that help in diagnosis and management.

1. Stable Angina (Chronic Exertional Angina)

Definition:
It is predictable chest pain that occurs on exertion or emotional stress and is relieved by rest or
nitroglycerin.

Features:

 Pain occurs at a predictable level of activity or stress.

 Follows a stable pattern in onset, duration, and intensity.
 Relieved by rest (within 5 minutes) or sublingual nitroglycerin.
 Caused by fixed atherosclerotic narrowing of coronary arteries that limits blood flow during increased
demand.
 Pain described as tightness, heaviness, squeezing, or pressure in chest, radiating to left arm, neck, or
jaw.

Example:
A patient who gets chest pain after climbing two flights of stairs every day experiences stable angina.

2. Unstable Angina (Pre-Infarction or Crescendo Angina)

Definition:
Unstable angina is unpredictable chest pain that occurs with minimal exertion or at rest and is not relieved by
rest or nitroglycerin.
It indicates worsening ischemia and high risk of myocardial infarction.

Features:

 Pain occurs at lower threshold of activity than before.

 Duration and severity are increasing (crescendo type).
 May occur at rest or during sleep.
 Not relieved by nitroglycerin or rest.
 Often associated with plaque rupture and thrombus formation in coronary arteries.

Clinical importance:
It is a medical emergency — a warning sign of impending myocardial infarction.

3. Variant Angina (Prinzmetal’s or Vasospastic Angina)

Definition:
Chest pain that occurs at rest due to coronary artery spasm rather than fixed obstruction.

Features:

 Occurs at rest, often during night or early morning.

 Caused by spasm of major coronary artery.
 ECG shows reversible ST-segment elevation during pain episode.
 Pain is often severe and may be accompanied by palpitations or syncope.
 May or may not be associated with atherosclerosis.

Relief:
Relieved by calcium channel blockers (like nifedipine) and nitrates, which reduce spasm.

4. Intractable or Refractory Angina

Definition:
Chronic, severe, disabling angina that does not respond to conventional medical or surgical treatment.

Features:

 Persistent chest pain despite use of medications, angioplasty, or bypass surgery.

 Associated with extensive coronary artery disease where further revascularization is not possible.
 Pain may be continuous or frequent, severely limiting patient’s activity.
 Requires advanced pain control methods (e.g., transmyocardial laser revascularization, spinal cord
stimulation).

5. Nocturnal Angina

Definition:
Chest pain that occurs at night during sleep, often associated with rapid eye movement (REM) dreaming
phase.

Features:

 Occurs while sleeping and awakens the patient.

 May be due to increased heart rate and blood pressure during REM sleep.
 Sometimes related to left ventricular failure or vasospasm.
 Pain subsides after sitting upright or taking nitroglycerin.

6. Angina Decubitus

Definition:
Chest pain that occurs while lying down (supine) and is relieved by sitting or standing up.
Features:

 Seen in patients with left ventricular dysfunction or heart failure.

 When lying down, venous return increases, causing more work for the heart and triggering ischemia.
 Relieved when patient sits up, reducing venous return and workload.

7. Post-Infarction Angina

Definition:
Angina pain that occurs after a recent myocardial infarction, due to residual ischemia in the heart muscle.

Features:

 Appears within days or weeks after MI.

 Pain usually lasts more than 15 minutes.
 Indicates incomplete revascularization or progression of coronary artery disease.
 Associated with acute coronary insufficiency and high risk of recurrent infarction.

Clinical importance:
Requires urgent evaluation and management to prevent another cardiac event.

Investigations for Angina Pectoris

Definition:
Angina pectoris is chest pain or discomfort that occurs when the myocardial oxygen demand exceeds the
oxygen supply, usually due to coronary artery disease (CAD).
Investigations help to confirm diagnosis, assess the severity of ischemia, identify the underlying cause, and plan
management.

1. Physical Examination

Before diagnostic tests, a thorough physical assessment is done to detect:

 Presence of risk factors (hypertension, diabetes, obesity, smoking)

 Pulse rate and rhythm
 Blood pressure in both arms
 Presence of cardiac murmurs or extra heart sounds
 Signs of heart failure (edema, jugular venous distension, crackles)
 Skin color (pallor, cyanosis) and temperature of extremities
2. Electrocardiogram (ECG / EKG)

Purpose: To detect ischemic changes or cardiac rhythm abnormalities.

Findings:

 ST-segment depression or T-wave inversion → indicates myocardial ischemia

 ST-segment elevation → may indicate acute myocardial infarction
 Arrhythmias such as premature ventricular contractions may appear during pain
 Normal ECG does not rule out angina, especially in stable cases

Types:

 Resting ECG – taken during chest pain and after relief

 Ambulatory (Holter) ECG – 24-hour continuous monitoring to detect transient ischemic episodes

3. Exercise Tolerance Test (ETT) / Treadmill Test (TMT)

Purpose:
To evaluate heart function under physical stress and determine the presence of exercise-induced ischemia.

Procedure:

 The patient walks on a treadmill or pedals a bicycle ergometer.

 The speed and incline increase gradually.
 Continuous ECG, heart rate, and blood pressure are monitored.

Findings:

 ST-segment depression, chest pain, or dyspnea during exercise → positive test for ischemia.
 Helps determine the functional capacity and exercise tolerance.

Nursing Responsibilities:

 Obtain informed consent.

 Instruct patient to avoid heavy meals and caffeine before test.
 Stop the test immediately if severe pain, dizziness, or ECG changes occur.

4. Echocardiography (ECHO)

Purpose:
To assess cardiac structure and function, wall motion, and ejection fraction.

Findings:

 Detects wall motion abnormalities due to ischemia or infarction.

 Measures left ventricular function and valvular abnormalities.
  Can identify complications like cardiomyopathy, aneurysm, or pericardial effusion.

Types:

 Transthoracic echocardiography (TTE) – routine, non-invasive.

 Transesophageal echocardiography (TEE) – provides clearer view of posterior structures of the heart.

5. Chest X-ray

Purpose:
To detect structural or secondary changes in the heart and lungs.

Findings:

 Cardiomegaly (enlarged heart)

 Signs of heart failure (pulmonary congestion, edema)
 Aortic dilatation or calcification
 Rule out other causes of chest pain (e.g., pneumonia, pleural effusion)

6. Coronary Angiography (Cardiac Catheterization)

Purpose:
The gold standard investigation to visualize coronary arteries and detect blockages.

Procedure:

 A catheter is inserted via femoral or radial artery and contrast dye is injected.
 X-ray images (angiograms) show location, number, and degree of coronary artery stenosis.

Findings:

 Normal coronary arteries → non-cardiac cause of pain

 Narrowed or blocked arteries → confirm diagnosis of coronary artery disease

Nursing Responsibilities:

 Obtain written consent.

 Check for allergy to iodine or contrast dye.
 Keep patient NPO (nothing by mouth) 4–6 hours before the test.
 Post-procedure, observe for bleeding, hematoma, and vital sign changes.

7. Blood Tests / Cardiac Enzymes

Although mainly used to rule out myocardial infarction, these help in assessing myocardial injury.
 Test Purpose / Finding

Troponin T / I Elevation indicates myocardial damage; normal in pure angina.

Creatine Kinase – MB (CK-MB) May slightly elevate in unstable angina or infarction.

LDH (Lactate Dehydrogenase) Rises later after myocardial injury.

AST (SGOT) May rise in cardiac injury but nonspecific.

8. Blood Lipid Profile

Purpose:
To assess risk factors for atherosclerosis and coronary artery disease.

Tests Include:

 Total cholesterol
 Low-density lipoprotein (LDL)
 High-density lipoprotein (HDL)
 Triglycerides

Findings:

 ↑ LDL & triglycerides and ↓ HDL increase risk of coronary artery disease.

9. CT Coronary Angiography (Non-invasive)

Purpose:
To visualize coronary arteries without invasive catheterization.

Advantages:

 Less discomfort and risk.

 Provides detailed 3D images of coronary vessels.

Disadvantages:

 Involves radiation exposure.

 Not suitable for patients with irregular heart rhythm or contrast dye allergy.

10. Nuclear Cardiac Imaging (Myocardial Perfusion Scan)

Purpose:
To evaluate blood flow and perfusion to different areas of the myocardium.
Procedure:

 A small dose of radioactive tracer (like thallium or technetium) is injected.

 Images are taken during rest and stress phases.

Findings:

 Decreased uptake in areas with poor perfusion indicates ischemia.

 Fixed defect = old infarct, reversible defect = ischemia.

11. Other Laboratory Investigations

Test Purpose / Finding

Blood glucose Detects diabetes mellitus, a major risk factor.

Renal function tests (BUN, Creatinine) Required before giving contrast dye.

Complete Blood Count (CBC) Detects anemia that may worsen ischemia.

Electrolyte levels Important for cardiac rhythm stability.

12. Holter Monitoring (24-hour Ambulatory ECG)

Purpose:
To record continuous ECG for 24–48 hours to detect intermittent ischemia, arrhythmias, or silent angina.

Nursing Role:

 Instruct patient to maintain a daily diary of activities and symptoms.

 Avoid wetting electrodes during monitoring period.

Medical Management of Angina Pectoris

Objectives of Medical Management

The main goals of treating angina pectoris are to:

1. Decrease myocardial oxygen demand

o Reduce the workload of the heart (by lowering heart rate, blood pressure, and contractility).
2. Increase myocardial oxygen supply
o Improve coronary blood flow through vasodilation and reduction of coronary spasm.
3. Prevent complications
o Prevent progression to myocardial infarction, arrhythmia, or heart failure.
 4. Control risk factors
o Manage lifestyle and medical conditions that worsen ischemia (such as hypertension, diabetes,
smoking, and hyperlipidemia).

Pharmacological Management of Angina Pectoris

The main goals of pharmacologic therapy are to relieve symptoms, reduce myocardial oxygen demand,
increase oxygen supply, and prevent complications such as myocardial infarction (MI) and sudden cardiac
death.

Management

i) Vasodilators

➡ Purpose:
To dilate coronary and systemic blood vessels, reduce myocardial oxygen consumption, and relieve chest pain.

a) Short-acting nitrates:

 Drug: Nitroglycerin (Sublingual tablet or translingual spray)

 Mechanism:
o Causes venous and arterial dilation, leading to:
 ↓ Preload (filling pressure)
 ↓ Afterload (resistance)
 ↓ Myocardial oxygen demand
o Improves coronary blood flow.
 Dose: 1 tablet sublingually or 1 metered spray; relieves pain within 3 minutes.
 Nursing Note:
o Sit or lie down while taking.
o May cause headache or hypotension.
o Store tablets in dark, airtight container.

b) Long-acting nitrates:

 Use: To maintain vasodilation and prevent angina attacks.

 Drugs: Isosorbide Dinitrate (Isordil), Isosorbide Mononitrate (Imdur)
 Nursing Note: Allow a nitrate-free period daily to prevent tolerance.

ii) Beta-Adrenergic Blockers (β-blockers)

➡ Purpose:
Reduce the heart’s workload and oxygen consumption by blocking sympathetic stimulation.

Mechanism of Action:

 ↓ Heart rate
  ↓ Myocardial contractility
 ↓ Systemic vascular resistance (SVR) and BP

Common Drugs:

 Propranolol, Atenolol, Metoprolol

Benefits:

 Reduces frequency of angina attacks

 Prevents reinfarction and cardiac mortality

Side Effects:

 Bradycardia, hypotension, fatigue, depression

 Avoid abrupt withdrawal
 Contraindicated in asthma and heart block.

iii) Calcium Channel Blockers (CCBs)

➡ Purpose:
Dilate coronary arteries, improve oxygen supply, and reduce workload on the heart.

Mechanism:

 Inhibit calcium entry into cardiac and smooth muscle cells.

 Promote coronary vasodilation and smooth muscle relaxation.
 Prevent coronary artery spasm.

Common Drugs:

 Amlodipine, Diltiazem, Nifedipine, Nicardipine

Uses:

 Useful when β-blockers are contraindicated.

Side Effects:

 Hypotension, dizziness, edema, constipation.

iv) Angiotensin-Converting Enzyme (ACE) Inhibitors

➡ Purpose:
Improve endothelial function and reduce cardiac workload.

Mechanism:
  Block conversion of Angiotensin I → Angiotensin II, leading to vasodilation.
 Decrease afterload and prevent cardiac remodeling.

Common Drugs:

 Captopril, Enalapril, Ramipril

Indications:

 Used in CAD with hypertension, diabetes, MI, or chronic kidney disease.

v) Antiplatelet Drugs

➡ Purpose:
Prevent clot formation and reduce the risk of MI.

Mechanism:

 Inhibit platelet aggregation.

Common Drugs:

 Aspirin: Inhibits thromboxane A₂ formation (a platelet activator).

 Clopidogrel: Used when aspirin is contraindicated.

Nursing Note:

 Monitor for bleeding or gastric irritation.

vi) Anticoagulant Drugs

➡ Purpose:
Prevent thrombus formation and reduce the risk of MI or cardiac arrest.

Mechanism:

 Inhibit blood clotting factors.

Common Drugs:

 Unfractionated heparin (Heparin sodium) — IV route.

 Low molecular weight heparins: Enoxaparin, Dalteparin.

Nursing Note:

 Monitor PTT (for heparin) or platelet count.

 Observe for signs of bleeding or bruising.
 🫀 Treadmill Test (TMT)
Definition

(Also called Exercise Stress Test or Exercise Tolerance Test)

The Treadmill Test (TMT) or Exercise Stress Test is a non-invasive diagnostic procedure used to evaluate
the functional capacity of the heart and its response to increased physical stress.
It helps to detect myocardial ischemia, arrhythmias, and exercise tolerance by recording
electrocardiographic (ECG) changes, blood pressure, and heart rate during graded exercise on a treadmill.

Purpose / Objectives

1. To detect coronary artery disease (CAD) and myocardial ischemia.

2. To evaluate chest pain and differentiate cardiac from non-cardiac causes.
3. To determine exercise tolerance and physical fitness level.
4. To assess effectiveness of cardiac treatment (e.g., after angioplasty or CABG).
5. To detect exercise-induced arrhythmias or conduction defects.
6. To assess prognosis in patients with known heart disease.
7. To evaluate effect of drugs such as beta-blockers or nitrates.
8. To screen asymptomatic individuals at high risk for CAD.

Principle

During exercise, myocardial oxygen demand rises due to an increase in heart rate, blood pressure, and
contractility.
If coronary arteries are narrowed, the oxygen supply becomes inadequate, causing ischemia, which manifests
as:

 ST-segment depression or elevation on ECG,

 Anginal pain, or
 Arrhythmias.

Thus, by comparing ECG and hemodynamic responses at rest and during exercise, ischemic heart disease can
be detected.

Equipment Required:

1. Motorized Treadmill – Programmable to increase speed and incline at set intervals.

2. 12-lead ECG machine – For continuous monitoring of cardiac rhythm.
3. Automatic Blood Pressure Monitor – For BP measurement during each stage.
4. Pulse Oximeter – To monitor oxygen saturation.
5. Defibrillator and emergency resuscitation equipment – For safety.
6. Emergency drugs – Nitroglycerin, oxygen, atropine, adrenaline, etc.
Indications

 Suspected or known coronary artery disease

 Evaluation of chest pain or atypical angina
 Assessment of post-MI functional recovery
 Evaluation before cardiac rehabilitation or surgery
 Assessment of exercise tolerance or physical fitness

Contraindications

Absolute Contraindications

 Acute myocardial infarction (within 2 days)

 Unstable angina
 Uncontrolled arrhythmias
 Severe aortic stenosis
 Acute myocarditis or pericarditis
 Acute pulmonary embolism

Relative Contraindications

 Left main coronary artery stenosis

 Moderate valvular heart disease
 Uncontrolled hypertension
 Electrolyte imbalance
 Inability to exercise

Preparation of the Patient

1. Explain the purpose, procedure, and sensations expected.

2. Obtain written informed consent.
3. Instruct to avoid food, caffeine, smoking, and alcohol for 3 hours prior.
4. Wear comfortable clothes and shoes.
5. Record baseline ECG, BP, heart rate.
6. Ensure emergency equipment and trained personnel are available.
7. Discontinue certain medications (e.g., beta-blockers) if prescribed.

Procedure

The most commonly used method is the Bruce Protocol, in which the speed and incline of the treadmill
increase every 3 minutes.
 1. Baseline phase:
o Resting ECG, HR, and BP recorded.
2. Exercise phase:
o Patient walks on treadmill; workload increases in stages.
o Continuous ECG and HR monitoring.
o BP measured every 3 minutes.
o Patient observed for chest pain, dyspnea, fatigue, or dizziness.
3. Test termination criteria:
o Onset of angina or severe dyspnea
o Significant ST-segment changes (> 1 mm depression/elevation)
o Severe arrhythmia or conduction block
o Excessive rise or fall in BP
o Patient fatigue or request to stop
o Achievement of target heart rate = 85 % of (220 − age)
4. Recovery phase:
o ECG and vitals monitored for 6–10 minutes until baseline values return.

Interpretation of Results

Finding Interpretation

Normal ECG response No ST-segment changes, no symptoms

Positive / Abnormal ≥ 1 mm ST-segment depression or elevation, chest pain, arrhythmia → indicates myocardial
test ischemia

Inconclusive Test stopped before achieving target HR without ECG changes

Complications

 Angina pectoris
 Arrhythmias
 Myocardial infarction (rare)
 Syncope or hypotension
 Dyspnea or exhaustion

Nursing Responsibilities

Before the Test

1. Explain procedure and obtain informed consent.

2. Record baseline vital signs and ECG.
3. Ensure emergency trolley and defibrillator are available.
4. Advise patient to report any pain or discomfort immediately.
During the Test

1. Observe for chest pain, fatigue, shortness of breath, dizziness.

2. Continuously monitor ECG, heart rate, and BP.
3. Stop test immediately if serious symptoms or ECG changes appear.

After the Test

1. Keep the patient under observation until vitals stabilize.

2. Continue ECG monitoring during recovery phase.
3. Document findings and report abnormal results promptly.
4. Provide reassurance and rest to the patient.

Advantages

 Simple, safe, and non-invasive.

 Detects ischemia before symptoms occur.
 Assesses treatment response and prognosis.
 Cost-effective screening tool.

Limitations

 Not suitable for patients unable to exercise.

 False-positive or false-negative results possible.
 Cannot localize the exact site of coronary blockage.
 Less sensitive in elderly and women.
 Pacemaker
Definition:

A pacemaker is a small, battery-operated device implanted under the skin, usually in the chest or upper arm,
that helps regulate abnormal heart rhythms. It sends electrical impulses to the heart to maintain an
adequate heart rate when the heart beats too slowly (bradycardia) or irregularly.

Health Education for Patients with a Permanent Pacemaker

1. Understanding the Pacemaker

 A permanent pacemaker is a small battery-operated device implanted under the skin, usually in the
chest or upper arm, to regulate abnormal heart rhythms.
 It helps when the heart beats too slowly (bradycardia) or irregularly.
 Pacemakers may be single-chamber, dual-chamber, or biventricular, depending on the patient’s
condition.
 Patients should understand that the device does not cure heart disease, but helps prevent symptoms
like fainting, dizziness, and fatigue.

2. Postoperative Care

 Incision site care:

o Keep the area clean and dry.
o Avoid rubbing, scratching, or applying creams unless prescribed.
o Observe for swelling, redness, bleeding, or discharge.
 Arm movement restrictions:
o Avoid lifting the arm on the implanted side above shoulder level for 2–4 weeks.
o Avoid pushing, pulling, or strenuous upper body activity initially to prevent lead
displacement.
 Pain management:
o Mild pain is normal; prescribed analgesics can be taken as directed.

3. Physical Activity

 Gradually resume daily activities; walking is encouraged.

 Avoid high-impact sports, heavy lifting, or contact sports.
 Swimming is usually allowed after complete healing, but avoid strong electrical currents.
 Report any palpitations, dizziness, or fatigue during activity.

4. Medication Management

 Take all prescribed cardiac medications (beta-blockers, antiarrhythmics, anticoagulants).

  Avoid self-medication; some drugs may interfere with pacemaker function.
 Maintain a list of medications and share it with all healthcare providers.

5. Follow-Up Care

 Regular device checks:

o Usually every 3–12 months, depending on the device and patient condition.
o Includes battery check, lead function, and device programming.
 Remote monitoring may allow for early detection of malfunctions or arrhythmias.
 Always carry the pacemaker ID card, including manufacturer, model, and implantation date.

6. Recognizing Complications

 Signs to report immediately:

o Dizziness, fainting, or syncope
o Rapid or irregular heartbeat
o Shortness of breath
o Swelling in legs or sudden weight gain
o Chest pain or tightness
o Fever, redness, or discharge at incision site
 Potential complications:
o Infection at implantation site
o Lead displacement
o Device malfunction

7. Safety Precautions

 Electromagnetic interference (EMI):

o Avoid prolonged exposure to strong magnets, MRI machines (unless MRI-compatible), high-
voltage equipment.
 Household appliances:
o Most are safe (TV, microwave, computers), but keep mobile phones at least 6 inches away and
use on the opposite ear.
 Airport security:
o Pacemakers may set off detectors; inform security personnel.
 Medical procedures:
o Inform all healthcare providers about the pacemaker before MRI, diathermy, or
electrocautery.

8. Lifestyle Modifications

 Diet: Heart-healthy diet low in saturated fats, cholesterol, and salt.

  Exercise: Low- to moderate-intensity activities, avoiding strain on the chest.
 Avoid smoking and limit alcohol.
 Weight management and stress reduction techniques like meditation, yoga, or relaxation therapy.
 Monitor blood pressure and blood sugar regularly.

9. Psychological Support

 Anxiety about having a pacemaker is common; provide reassurance.

 Encourage participation in support groups for patients with cardiac devices.
 Educate family members about signs of complications and emergency response.
 Promote active involvement in self-care to improve confidence and independence.

10. Patient Education Reinforcement

 Provide written instructions on incision care, activity restrictions, and warning signs.
 Use visual aids or diagrams to explain device function.
 Reinforce importance of follow-up visits and adherence to medication.
 Encourage patients to keep a symptom diary (palpitations, dizziness, chest pain).

11. Emergency Preparedness

 Know how to contact healthcare provider or emergency services.

 Teach family members CPR if patient is at high risk of cardiac arrest.
 Have pacemaker information card accessible at all times.
 Abnormal Heart Sounds
Abnormal heart sounds occur during systole or diastole due to structural or functional heart problems. They
include:

 Gallops (S3, S4)

 Opening snaps
 Systolic clicks
 Murmurs
 Friction rubs
 Pericardial knock (rare)

Gallop sounds are low-frequency vibrations caused by rapid ventricular filling against a noncompliant
ventricle. The term “gallop” is derived from the rhythm resembling a galloping horse.

1. S3 – Third Heart Sound

 Timing: Early diastole (just after S2)

 Mnemonic: Lub-dub-DUB
 Mechanism: Blood enters a noncompliant ventricle, causing vibration.
 Normal vs Abnormal:
o Normal (physiologic) in children, young adults <40 years, athletes, and pregnancy
o Abnormal (pathologic) in older adults → may indicate heart failure, volume overload, dilated
cardiomyopathy
 Auscultation:
o Left-sided S3: Apical area, patient in left lateral position
o Right-sided S3: Tricuspid area, patient supine
 Clinical Significance: Suggests ventricular dysfunction

2. S4 – Fourth Heart Sound

 Timing: Late diastole (just before S1)

 Mnemonic: LUB lub-dub
 Mechanism: Blood enters a stiff, noncompliant ventricle during atrial contraction
 Causes:
o Hypertension
o Coronary artery disease
o Aortic stenosis
o Cardiomyopathies
 Auscultation:
o Left-sided S4: Apical area, patient in left lateral position
o Right-sided S4: Tricuspid area, patient supine
 Clinical Significance: Indicates ventricular stiffness, hypertrophy, or ischemia
  Special: S3 + S4 → quadruple rhythm (“LUB lub-dub DUB”); summation gallop during tachycardia

3. Opening Snaps

 Timing: Early diastole

 Mechanism: Rigid AV valve leaflets snap open due to high atrial pressure
 Example: Mitral stenosis → high-pitched early diastolic snap
 Differentiation:
o Too late after S2 for split S2
o Too early in diastole for S3
 Auscultation: Diaphragm, medial apical area, lower left sternal border
 Clinical Significance: Indicates valvular stenosis; often followed by a diastolic murmur

4. Systolic Clicks

 Timing: Early, mid, or late systole

 Mechanism: Abnormal motion of valve leaflets during ventricular contraction
 Examples:
o Aortic/pulmonic stenosis: Early systolic click
o Mitral/tricuspid valve prolapse: Mid- to late systolic click
 Auscultation: Over the affected valve; often followed by a murmur
 Clinical Significance: Suggests valvular prolapse or stenosis

5. Murmurs

 Definition: Turbulent blood flow in the heart, producing a swishing or blowing sound
 Causes:
o Narrowed (stenotic) or malfunctioning (regurgitant) valves
o Congenital defects (VSD, PDA, ASD)
o Increased blood flow (hyperthyroidism, fever, pregnancy)
 Characteristics:
o Timing: Systolic or diastolic
o Location: Specific valve area
o Intensity: Grade I–VI
o Pitch: High, medium, low
o Quality: Blowing, harsh, rumbling
o Radiation: May radiate to neck, axilla, or back
 Clinical Significance: Suggests valvular disease or congenital defect

Characteristics of Heart Murmurs

Definition:
A heart murmur is an abnormal heart sound produced by turbulent blood flow through the heart or great
vessels.
Murmurs are described based on several characteristics—these help identify the type, location, and possible
cause of the murmur.

1. Location

 The site where the murmur is heard the loudest helps to identify which valve or cardiac structure is
involved.
 The anatomic landmarks (intercostal spaces and chest lines) are used to describe the exact location.

Common Locations:

 Aortic area: Right 2nd intercostal space, close to sternal border

 Pulmonic area: Left 2nd intercostal space
 Tricuspid area: Left 4th–5th intercostal space, near sternal border
 Mitral (apical) area: Left 5th intercostal space, midclavicular line

Example:

 Murmur of Ventricular Septal Defect (VSD) – best heard at the left sternal border, 3rd–4th
intercostal space.
 Murmur of Aortic Stenosis – best heard at right 2nd intercostal space and may radiate to the neck.

2. Timing

 Describes when the murmur occurs in the cardiac cycle:

o Systolic murmur → occurs between S₁ and S₂
o Diastolic murmur → occurs between S₂ and S₁
o Continuous murmur → heard throughout both systole and diastole

Examples:

 Systolic murmurs: Aortic stenosis, Mitral regurgitation, VSD

 Diastolic murmurs: Mitral stenosis, Aortic regurgitation
 Continuous murmurs: Patent ductus arteriosus (PDA)

🩺 Skilled clinicians can further describe them as:

 Early, Mid, or Late systolic/diastolic murmur

3. Intensity (Loudness)

 The grade of a murmur describes how loud it sounds.

 Murmurs are graded on a six-point scale:
 Grade Description

Grade 1 Very faint, heard only after careful listening

Grade 2 Quiet but easily heard by an experienced listener

Grade 3 Moderately loud, without thrill

Grade 4 Loud, may be associated with a palpable thrill

Grade 5 Very loud, heard with stethoscope partially off chest; thrill present

Grade 6 Extremely loud, audible with stethoscope off chest; thrill present

👉 Thrill: A palpable vibration over the chest wall caused by turbulent flow, often in grade 4–6 murmurs.

4. Pitch

 Refers to the frequency (tone) of the murmur — high, medium, or low.

 The part of the stethoscope used depends on the pitch:

Pitch Best Heard With

High-pitched murmurs Diaphragm of stethoscope (pressed firmly)

Low-pitched murmurs Bell of stethoscope (placed lightly)

Examples:

 Aortic regurgitation: High-pitched, blowing murmur

 Mitral stenosis: Low-pitched, rumbling murmur

5. Quality

 Refers to the character or sound type of the murmur.

 Common descriptions include:
o Blowing
o Rumbling
o Whistling
o Harsh
o Musical

Examples:

 Mitral or Tricuspid regurgitation: Blowing quality

  Mitral stenosis: Rumbling quality
 Aortic stenosis: Harsh, rough quality

6. Radiation

 Radiation refers to the transmission of the murmur sound from its point of origin to other areas of the
chest or body.
 It helps identify the direction of blood flow and underlying valve pathology.

Examples:

 Aortic stenosis: Murmur radiates to carotid arteries (neck).

 Mitral regurgitation: Murmur radiates to left axilla.
 Pulmonic stenosis: May radiate to left shoulder or back.

6. Friction Rub

 Timing: Systole and diastole

 Mechanism: Inflamed pericardial surfaces rub against each other
 Sound: Harsh, grating, scratching
 Auscultation: Diaphragm, patient sitting up and leaning forward
 Clinical Significance: Suggests pericarditis
 Differentiation: Can be confused with murmurs; distinct scratchy quality

7. Pericardial Knock (Optional)

 Timing: Early diastole, shortly after S2

 Mechanism: Abrupt cessation of ventricular filling due to constrictive pericarditis
 Sound: Loud, high-pitched, and short
 Clinical Significance: Rare; indicates rigid pericardium
 Treadmill Test (TMT) / Exercise Stress Test
Definition:

The treadmill test is a non-invasive diagnostic procedure used to evaluate the heart’s response to
increased workload. It is primarily used to detect coronary artery disease (CAD), arrhythmias, and
exercise-induced symptoms.

Purpose / Indications

1. Diagnosis of CAD in patients with chest pain or risk factors.

2. Assessment of exercise tolerance and functional capacity.
3. Evaluation of effectiveness of cardiac treatment (medications, angioplasty, or surgery).
4. Detection of exercise-induced arrhythmias or ischemia.
5. Preoperative cardiac risk assessment in selected patients.

Contraindications

Absolute Contraindications:

 Acute myocardial infarction (within 2 days)

 Unstable angina
 Severe aortic stenosis
 Uncontrolled heart failure
 Active severe infection or pulmonary embolism

Relative Contraindications:

 Severe hypertension
 Moderate valvular heart disease
 Electrolyte imbalance
 Recent stroke or TIA

Preparation

 Patient education: Explain procedure, sensations, and risks.

 Fasting: Light meal 2–3 hours before; avoid caffeine, smoking, alcohol, and heavy meals.
 Medications: May need to hold beta-blockers or nitrates as per physician’s orders.
 Clothing: Comfortable shoes and clothing suitable for exercise.
 Monitoring: ECG electrodes placed; blood pressure cuff ready.

Procedure
 1. Patient walks on a treadmill following a graded protocol (e.g., Bruce protocol) that increases speed
and incline every 3 minutes.
2. Continuous ECG monitoring for heart rate, rhythm, and ST-segment changes.
3. Blood pressure measured at intervals.
4. Test continues until:
o Target heart rate achieved (usually 85% of maximum predicted)
o Patient develops symptoms (chest pain, dizziness, fatigue)
o ECG changes indicating ischemia appear
5. Recovery phase: Patient monitored until vitals stabilize.

Interpretation

 Positive Test: Reproduction of angina or ST-segment depression/elevation on ECG → suggests

myocardial ischemia.
 Negative Test: No angina or ECG changes → low likelihood of significant CAD.
 Inconclusive Test: Unable to reach target heart rate or abnormal baseline ECG → further evaluation
needed.

Advantages

 Non-invasive and relatively safe

 Provides functional assessment of heart
 Helps plan exercise programs and guide treatment

Limitations

 Cannot visualize coronary arteries directly

 May be false-positive (e.g., in women, baseline ECG abnormalities)
 Requires patient to be physically capable of exercise
 Medications may affect results

Nursing Considerations

Before Test:

 Assess baseline vitals and ECG

 Explain procedure, expected sensations, and signs to report
 Ensure informed consent

During Test:

 Continuous monitoring of ECG, BP, symptoms

 Watch for chest pain, dizziness, shortness of breath
 Be ready for emergency intervention
After Test:

 Monitor until heart rate and BP return to baseline

 Record ECG changes and patient response
 Educate patient on resuming medications, activity, and follow-up
 Cardiac Enzyme Analysis
Definition:

Cardiac enzyme analysis is a diagnostic test used to measure specific enzymes and proteins released into the
blood when the heart muscle (myocardium) is damaged, such as during a myocardial infarction (heart
attack).

These enzyme levels, when interpreted with the patient’s history, symptoms, and ECG findings, help confirm
or rule out acute myocardial infarction (MI).

Pathophysiology / Mechanism:

 When myocardial cells are injured due to ischemia, infarction, or trauma, their cell membranes
rupture.
 This releases enzymes and proteins from inside the cardiac cells into the interstitial fluid and
eventually into the bloodstream via the lymphatic and coronary circulation.
 Measuring these serum enzyme levels helps identify the occurrence, timing, and extent of cardiac
muscle damage.

Key Principle:

Different enzymes enter the bloodstream at different time intervals after myocardial injury.
👉 Therefore, serial measurements (every few hours) are important to interpret the pattern of rise and fall of
enzyme levels.

Important Cardiac Enzymes and Markers

1. Creatine Kinase (CK)

 First enzyme to rise after myocardial infarction.

 Found in skeletal muscle, brain, and cardiac tissue.
 CK-MB (MB isoenzyme) is the specific cardiac form.
 Time course:
o Rises: 3–6 hours after onset of chest pain
o Peaks: 12–24 hours
o Returns to normal: 2–3 days
 Significance:
o CK-MB levels correlate with the size of infarct.
o Helpful in detecting reinfarction (because it returns to normal faster than Troponin).
2. Lactate Dehydrogenase (LDH)

 LDH and its isoenzymes (especially LDH-1) are also released during myocardial damage.
 Time course:
o Rises: 12–24 hours after MI
o Peaks: 48–72 hours
o Returns to normal: 7–10 days
 Significance:
o Useful for diagnosing late presenters (patients who seek care days after MI).
o LDH-1 level higher than LDH-2 is suggestive of myocardial infarction (called “LDH flip”).

3. Myoglobin

 A heme protein with small molecular weight, found in cardiac and skeletal muscles.
 First marker to appear in blood after MI because it is released rapidly from damaged muscle.
 Time course:
o Rises: 1–3 hours after onset of MI
o Peaks: 4–12 hours
o Returns to normal: 24 hours
 Significance:
o Early indicator of myocardial injury.
o Not specific to the heart (also rises in renal disease or muscle injury).
o Negative myoglobin test helps rule out early MI.

4. Troponin (Troponin I and Troponin T)

 Most specific and sensitive marker for myocardial injury.

 Troponin I is a contractile protein found only in cardiac muscle (not in skeletal muscle).
 Time course:
o Rises: 3–4 hours after onset
o Peaks: 4–24 hours
o Remains elevated: 1–3 weeks
 Significance:
o Detects both early and late myocardial damage.
o Allows diagnosis even when patient presents days after MI.
o Helps differentiate cardiac from skeletal muscle injury.

Summary Table of Cardiac Enzymes

Enzyme / Marker Rise (hrs) Peak (hrs) Return to Normal Specificity Remarks

CK-MB 3–6 12–24 2–3 days Moderate Useful for reinfarction

LDH 12–24 48–72 7–10 days Low Late marker, “LDH flip” in MI
Enzyme / Marker Rise (hrs) Peak (hrs) Return to Normal Specificity Remarks

Myoglobin 1–3 4–12 24 hrs Low Early marker, not cardiac-specific

Troponin I/T 3–4 4–24 7–21 days Very High Most specific, gold standard

Clinical Applications:

1. Diagnosis of MI:
o A rise and fall of cardiac enzyme levels confirms myocardial damage.
2. Assessment of Infarct Size:
o Higher enzyme levels → larger area of myocardial necrosis.
3. Detection of Reinfarction:
o CK-MB is useful due to its short half-life.
4. Monitoring Therapy:
o Track effectiveness of reperfusion therapy (thrombolytics, angioplasty).

Nursing Responsibilities:

1. Before Test:
o Explain purpose and procedure of test to patient.
o Record time of chest pain onset for accurate interpretation.
o Obtain blood sample using aseptic technique.
2. During Test:
o Monitor vital signs and ECG changes.
o Observe for recurrent chest pain or arrhythmias.
3. After Test:
o Record and report enzyme levels promptly to physician.
o Provide emotional support; discuss test results as needed.
o Reinforce lifestyle modification and medication adherence if MI confirmed.